Literature DB >> 11225898

Ambulatory urodynamic monitoring of external urethral sphincter behavior in chronic prostatitis patients.

L M Liao1, B Y Shi, C Q Liang.   

Abstract

AIM: To study the behavior of external urethral sphincter in chronic prostatitis (CP) patient under natural filling.
METHODS: Twenty-one CP patients and 17 normal volunteers were involved in the study. Both the patients and volunteers underwent ambulatory urodynamic monitoring (AM) and conventional medium filling cystometry (CMG). Urodec 500 was used for AM and Menuet for CMG. AM findings from CP patients were compared with those from normal volunteers, and the results from AM were compared with those from CMG.
RESULTS: In AM, the resting and voiding external urethral sphincter (EUS) pressures and maximum urethral closure pressures (MUCP) were significantly higher in CP patients [(121.5 +/- 10.3) and (85. 6 +/- 3.5) cm water, respectively] than in normal volunteers [(77.6 +/- 11.4) and (10.3 + 1.6) cm water, respectively)].
CONCLUSION: The behavioral changes of EUS in CP patients included spasm and instability of EUS, which were demonstrated using AM under natural filling; the findings were also in accord with the results of CMG.

Entities:  

Mesh:

Year:  1999        PMID: 11225898

Source DB:  PubMed          Journal:  Asian J Androl        ISSN: 1008-682X            Impact factor:   3.285


  3 in total

1.  Effects of a 6-month course of tamsulosin for chronic prostatitis/chronic pelvic pain syndrome: a multicenter, randomized trial.

Authors:  Yong Chen; Xiaohou Wu; Jia Liu; Wei Tang; Tao Zhao; Jianhua Zhang
Journal:  World J Urol       Date:  2010-03-25       Impact factor: 4.226

2.  Current treatment options in the management of chronic prostatitis.

Authors:  Alain Jean Duclos; Chun-Te Lee; Daniel Arthur Shoskes
Journal:  Ther Clin Risk Manag       Date:  2007-08       Impact factor: 2.423

3.  Resveratrol improves prostate fibrosis during progression of urinary dysfunction in chronic prostatitis by mast cell suppression.

Authors:  Huizhi Zeng; Yi He; Yang Yu; Jiashu Zhang; Xiaona Zeng; Fengtao Gong; Qi Liu; Bo Yang
Journal:  Mol Med Rep       Date:  2017-11-03       Impact factor: 2.952

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.